Publications by authors named "Dana Sponerova"

Article Synopsis
  • Downregulation of the CRBN gene is linked to lenalidomide resistance and poor outcomes in multiple myeloma patients, but its role in myelodysplastic syndrome (MDS) remains unclear.
  • This study examined CRBN expression in bone marrow and peripheral blood from various MDS patients and healthy controls, revealing that patients with 5q deletion (5q-) exhibited the highest CRBN mRNA levels.
  • High CRBN levels were found in patients who responded well to lenalidomide, while decreased levels during treatment were associated with loss of response and disease progression, indicating CRBN's importance for the drug's effectiveness in MDS.
View Article and Find Full Text PDF

Background: Interactions between genetic variants and risk factors in myelodysplastic syndromes are poorly understood. In this case-control study, we analyzed 1 421 single nucleotide polymorphisms in 408 genes involved in cancer-related pathways in 198 patients and 292 controls.

Methods: The Illumina SNP Cancer Panel was used for genotyping of samples.

View Article and Find Full Text PDF

Friend leukemia virus integration 1 (Fli1) and erythroid Krüppel-like factor (EKLF) participate under experimental conditions in the differentiation of megakaryocytic and erythroid progenitor in cooperation with other transcription factors, cytokines, cytokine receptors, and microRNAs. Defective erythropoiesis with refractory anemia and effective megakaryopoiesis with normal or increased platelet count is typical for 5q- syndrome. We decided to evaluate the roles of EKLF and Fli1 in the pathogenesis of this syndrome and of another ribosomopathy, Diamond-Blackfan anemia (DBA).

View Article and Find Full Text PDF

C/EBPalpha (CCAAT/enhancer binding protein alpha) belongs to the family of leucine zipper transcription factors and is necessary for transcriptional control of granulocyte, adipocyte and hepatocyte differentiation, glucose metabolism and lung development. C/EBPalpha is encoded by an intronless gene. CEBPA mutations cause a myeloid differentiation block and were detected in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), multiple myeloma and non-Hodgkin's lymphoma (NHL) patients.

View Article and Find Full Text PDF